Lipid-lowering agents and risk of melanoma

✍ Scribed by Robert S. Kirsner; Claudia C. Ramirez; Daniel G. Federman; Fangchao Ma

• Book ID: 102272651
• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: French
• Weight: 39 KB
• Volume: 117
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/ijc.21181

✦ Synopsis

A Population-Based Cohort Study'' published in the 1 December edition of the International Journal of Cancer, in which Friis et al. reported a reduction of cancer risk in statins users. Other studies have suggested that statins and other lipid-lowering agents (in contrast to the findings of Friis et al.) to be beneficial for other diseases including cancer.

Two randomized prospective studies conducted to evaluate the effects of lovastatin 1 and gemfibrozil 2 in coronary artery disease observed a significantly lower incidence of melanoma in patients randomized to receive those lipid-lowering agents.